SITEMAN CANCER CENTER at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis was awarded an “exceptional” rating, the highest possible, by the NCI, based on a rigorous peer review of Siteman’s research programs. Siteman is an NCI-designated Comprehensive Cancer Center.
Siteman earned its rating based on a January site visit by 26 researchers and administrators from academic cancer centers across the U.S.
“While this rating speaks to the extraordinary quality of our research, many of our researchers also are physicians who treat patients,” said Timothy Eberlein, director of Siteman Cancer Center and head of the School of Medicine’s Department of Surgery. “Being recognized as exceptional by one’s peers makes our work on behalf of our patients even more meaningful.”
During the visit, Washington University researchers and physicians presented their research programs in genomics, cancer imaging, cancer prevention and disparities, immunology and immunotherapy, and early-phase clinical trials.
including: vaccines against breast cancer and melanoma; goggles that help surgeons visualize cancer cells in the operating room; community-based research to understand cancer disparities; and promoting patient participation in innovative clinical studies.
Siteman was named Missouri’s only NCI-designated Cancer Center in 2001 and the state’s only Comprehensive Cancer Center in 2005.
